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CASE REPORT
Successful Resection of a Giant Primary Liposarcoma of the
Posterior Mediastinum
Giuseppe Marulli, MD,* Federico Rea, MD,* Paolo Feltracco, MD,† Fiorella Calabrese, MD,‡
Cinzia Giacometti, MD,‡ Giovanna Rizzardi, MD,* Luigi Vincenzo, MD,§
and Francesco Sartori, MD*
Primary liposarcomas of the mediastinum are extremely rare neo-
plasms, comprising less than 1% of all mediastinal tumors. These
tumors occur most commonly in the lower extremities (75%) and
less frequently in the retroperitoneum. We present a case involving
a successful radical resection of a large myxoid liposarcoma and its
recurrence, both located in the posterior mediastinum.
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In September 2002, a 29-year-old woman was referred to oursurgical department because of massive opacification of the
left hemithorax on chest radiograph. The patient, who was a
non-smoker, presented with a persistent cough that was not
responsive to sedative drugs. Mild dyspnea at rest and tachy-
cardia had developed over a 1-month period. She had no
significant medical history, and, on physical examination,
absent breath sounds and dullness to percussion were noted
on the left side of the chest.
A total body computed tomography (CT) scan (Fig-
ure 1) showed a mass involving the entire left hemithorax
and the posterior mediastinum, with a marked mediastinal
shift to the right. The tumor was composed of large
lobulated masses with various soft tissue densities, and the
adjacent structures appeared compressed but not clearly
infiltrated. No other localization of the tumor was seen. A
magnetic resonance imaging (MRI) scan did not show
signs of invasion of the mediastinal structures or dia-
phragm. A core needle biopsy performed under CT guid-
ance was not conclusive for a preoperative pathological
diagnosis and only showed normal fat tissue composed of
mature adult fat cells. However, on the basis of the CT
scan and the large size of the mass, surgical exploration
was performed. A complete resection of the tumor from
the left pleural cavity and posterior mediastinum was made
through a posterior–anterior left thoracotomy; during the
operation, the substantial size of the mass created prob-
lems with its manipulation, causing compression of medi-
astinal structures and temporary arrhythmias. The tumor
was pseudo-encapsulated and had an expansive, non-infil-
trative growth, thus making the radical resection possible.
Major adhesions were noted in the paraaortic–paraesopha-
geal space, where the base implant seemed to be located.
Macroscopically, the resected specimen weighed 4910 g,
and its dimensions were 28  22  16 cm (Figure 2). The
cut surface was slimy with a yellowish tinge and was an
admixture of fleshy sarcoma-like areas and areas resem-
bling ordinary adipose tissue. Microscopically, the tumor
was composed of small uniform cells with scant cytoplasm
set in a myxoid matrix containing numerous capillaries
arranged in a plexiform pattern (Figure 3A). Scattered
among these cells was a variable amount of cells with a
clear vacuole or vacuoles that distorted and pushed aside
the thin nucleus (signet ring lipoblasts; Figure 3B). The
final diagnosis was consistent with a paucicellular myxoid
liposarcoma (MLS) originating from the posterior medias-
tinum. The postoperative course was uneventful; chest
radiograph documented the re-expansion of the left lung
and realignment of the mediastinum, and the patient was
discharged on the 11th day post-surgery. At 24-month
follow-up, evaluation with a chest CT scan showed a
relapse (dimensions, 5  3  2 cm) in the right paraesoph-
ageal space that was radically resected through a right
thoracoscopy. The tumor showed the same morphologic
features as the original mass, with clearly evident fat-laden
cells and signet ring lipoblasts merged into a mixoid
matrix containing thin-walled capillaries. At 24 months
after the second intervention, the patient was well and free
of disease.
DISCUSSION
MLS is the most common subtype of liposarcoma,
accounting for more than one third of liposarcomas and
representing approximately 10% of all adult soft tissue sar-
comas. MLS is a disease of young adults; the age at
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presentation is, on average, a decade younger than that
with other histological subtypes. It has a peak incidence in
the fourth and fifth decades of life.1 These tumors occur
preferentially in the deep soft tissue of the lower extrem-
ities (thigh, popliteal area, groin, and buttock), followed by
the retroperitoneum. The mediastinum is usually involved
as a metastatic site,2,3 whereas it represents an extremely
rare site of primary origin (0.5–1% of all mediastinal
tumors)4; liposarcomas are mainly located in the anterior
mediastinum. Microscopically, pure MLS is composed of a
hypocellular bland spindle cell proliferation set in a myx-
oid background. Lipoblasts are often monovacuolated and
tend to cluster around vessels. The most distinguishing
morphological clue to the diagnosis is the presence of a
thin-walled capillary network organized in a plexiform
“chicken-wire” pattern. Mitotic figures and necrosis are
uncommon. The differential diagnosis includes all the
neoplasms with a myxoid stroma. The cells composing
myxoid malignant fibrous histiocytoma (myxofibrosar-
coma) demonstrate greater nuclear pleomorphism and lack
cytoplasmic vacuoles. Diagnostic difficulties involving
myxoid liposarcoma sometimes occur, especially in rela-
tion to other types of liposarcomas and lipomatous neo-
plasms. However, atypical lipomatous tumors display a
population of cells with enlarged, dense, irregularly shaped
nuclei. The histological features of MLS are indistinguish-
able from those of lipoblastoma and lipoblastomatosis,
except for the lobulation found in many lipoblastomas.
The classification of liposarcoma often contains a cat-
egory formerly known as “round cell” liposarcoma (RC). A
subset of MLS shows histological progression to hypercellu-
lar or RC morphology, which is associated with a signifi-
cantly poorer prognosis. The recognition and quantification
of hypercellular/RC areas represent critical steps in the eval-
uation of MLS subtypes because hypercellularity seems to be
correlated with the clinical outcome. On the basis of the
percentage of hypercellularity/RC formation, MLS/RC (more
than 25% hypercellular/RC areas) and RC (more than 75%
hypercellular/RC areas) subtypes are recognized. The 5-year
survival probability is approximately 90% for pure MLS,
40–50% for MLS/RC, and less than 25% for RC.5 The
concept that MLS and RC may represent a morphological
continuum was validated by cytogenetic analysis demonstrat-
ing that MLS and RC share the same chromosome translo-
cation, i.e., t (12:16)(q13;p11), in more than 90% of cases.6
Kilpatrick et al.7 found that the presence of a high rate of RCs
(25%), an age of 45 years, and the presence of sponta-
neous tumor necrosis were significantly associated with a
poor prognosis.
The clinical behavior is usually characterized by slow
growth that is not infiltrative but that causes a gradual
compression of adjacent intrathoracic structures. Symptoms,
when present, include chest pain, cough, dyspnea, and man-
ifestations related to the compression of the heart and great
vessels (superior vena cava syndrome, cardiac tamponade,
tachycardia, arrhythmias). Despite the presence of a huge
mass causing complete atelectasis of the left lung and a
mediastinal shift of the heart to the right side, our patient did
not have significant symptoms. The slow growth of the mass
may have allowed the patient to gradually adapt. Some
authors8,9 have reported the effectiveness of fine-needle or
large-core biopsy under CT guidance for preoperative patho-
logical diagnosis; in the present case and in other reports,10
however, preoperative diagnosis was not possible. Despite
the ease with which the biopsy was performed, only mature
adipose tissue admixed with myxoid matrix was observed.
This may have been because of both the large size of the mass
and the peculiar heterogeneous morphological pattern of
FIGURE 2. Characteristics of the mass at gross examina-
tion. A yellowish cut surface with an admixture of fleshy sar-
coma-like and adipose tissue areas were observed. The tu-
mor was not encapsulated and presented a pseudocapsule
only focally.
FIGURE 1. The chest computed
tomographic scan shows a giant
mass almost completely occupying
the left hemithorax and the poste-
rior mediastinum with a shift of the
mediastinum to the right. The lob-
ulation and different densities in
various areas are evident.
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MLS in which highly cellular areas are admixed with foci
resembling normal adipose tissue.
The gold standard for the treatment of these tumors
is complete surgical excision.11 In our case, after the
successful resection of the tumor, we also obtained the
simultaneous re-expansion of the left lung, which had
completely collapsed, and realignment of the mediastinum.
Our patient was young, and, on pathological examination,
we found a low grade of cellularity and necrosis. On the
basis of these findings and because of the radical surgical
excision of the tumor, we did not proceed with adjuvant
treatment. Unfortunately, 2 years after the surgical exci-
sion, the patient presented with a local recurrence that
probably originated from the base implant of the tumor in
the posterior mediastinum; this recurrence was success-
fully resected. The rarity of this tumor is demonstrated by
the few documented cases (approximately 80 patients) in
two major reviews and some case reports.3,8,11,13 At this
moment, no clear data are available regarding the efficacy
of adjuvant treatments. The proposed chemotherapeutic
regimens are anecdotal and have not been proven effec-
tive.14 However, radiotherapy seems to be useful for the
local control of disease in cases that are not suitable for
surgery or not radically resected, but radiotherapy is of
little utility in the dosage that can be used in the medias-
tinum or chest cavity. Nevertheless, Burt et al.11 recom-
mended continued exploration of an aggressive adjuvant
treatment in consideration of the high percentage of local
recurrence (64%) even after radical resection.
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FIGURE 3. A, Uniform population of small elements with scant cytoplasm set in a myxoid matrix (arrowheads), with numer-
ous thin-walled capillaries organized in a plexiform “chicken-wire” pattern (arrows) was observed. Hematoxylin & eosin stain-
ing; original magnification, 50. B, A variable amount of mono- and multivacuolated cells was observed. The thin nucleus was
distorted and pushed aside by the vacuoles (signet ring lipoblasts). Hematoxylin & eosin staining; original magnification, 100.
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